We are live on ! Find out more
GT

Glenview Trust Portfolio holdings

AUM $7.23B
1-Year Est. Return 27.68%
This Fund
S&P 500
This Quarter Est. Return
+16.49%
1 Year Est. Return
+27.68%
3 Year Est. Return
+99.19%
5 Year Est. Return
+131.61%
10 Year Est. Return
AUM
$7.23B
AUM Growth
+$864M
Cap. Flow
+$101M
Cap. Flow %
1.39%
Top 10 Hldgs %
34.7%
Holding
533
New
33
Increased
204
Reduced
204
Closed
16

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$14.3M
2
VOT icon
Vanguard Morningstar Mid-Cap Growth ETF
VOT
+$7.86M
3
SPGI icon
S&P Global
SPGI
+$5.78M
4
NVDA icon
NVIDIA
NVDA
+$3.43M
5
HUM icon
Humana
HUM
+$2.77M

Sector Composition

Rank Sector Weight
1 Miscellaneous 29.79%
2 Technology 25.38%
3 Financials 9.57%
4 Healthcare 8.76%
5 Industrials 7.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VLO icon
101
Valero Energy
VLO
$107B
$12.7M 0.18%
48,679
-815
-2% -$201K
TMUS icon
102
T-Mobile US
TMUS
$195B
$12.6M 0.17%
75,074
-2,022
-3% -$383K
BF.B icon
103
Brown-Forman Class B
BF.B
$12.5B
$12.5M 0.17%
470,354
-5,858
-1% -$158K
ETN icon
104
Eaton
ETN
$158B
$12M 0.17%
28,053
+1,368
+5% +$552K
IBDU icon
105
iShares iBonds Dec 2029 Term Corporate ETF
IBDU
$3.95B
$11.8M 0.16%
510,500
+15,425
+3% +$358K
PEP icon
106
PepsiCo
PEP
$189B
$11.6M 0.16%
85,754
-2,275
-3% -$340K
NSC icon
107
Norfolk Southern
NSC
$74.1B
$11.5M 0.16%
36,527
-182
-0.5% -$56.1K
INTC icon
108
Intel
INTC
$502B
$11.4M 0.16%
81,978
+107
+0.1% +$10.8K
IDXX icon
109
Idexx Laboratories
IDXX
$41.9B
$11.4M 0.16%
21,707
-3,430
-14% -$1.92M
ROP icon
110
Roper Technologies
ROP
$40.4B
$11.3M 0.16%
33,386
+3,849
+13% +$1.31M
CB icon
111
Chubb
CB
$133B
$11.1M 0.15%
32,714
-1,145
-3% -$373K
IBDV icon
112
iShares iBonds Dec 2030 Term Corporate ETF
IBDV
$3.29B
$11M 0.15%
506,320
+25,508
+5% +$556K
EW icon
113
Edwards Lifesciences
EW
$51.7B
$11M 0.15%
121,885
-4,326
-3% -$362K
BDX icon
114
Becton Dickinson
BDX
$50.9B
$10.9M 0.15%
72,242
+2,466
+4% +$369K
SCHW
115
Charles Schwab
SCHW
$189B
$10.9M 0.15%
118,279
-2,271
-2% -$207K
BSX icon
116
Boston Scientific
BSX
$69.2B
$10.8M 0.15%
254,089
+32,757
+15% +$1.78M
ASML icon
117
ASML
ASML
$656B
$10.8M 0.15%
5,417
+501
+10% +$797K
TFLO icon
118
iShares Treasury Floating Rate Bond ETF
TFLO
$6.66B
$10.8M 0.15%
212,666
-1,087
-0.5% -$55K
PFE icon
119
Pfizer
PFE
$163B
$10.7M 0.15%
442,787
+6,415
+1% +$168K
CSX icon
120
CSX Corp
CSX
$91.5B
$10.2M 0.14%
214,903
-16,036
-7% -$724K
TGT icon
121
Target
TGT
$74.4B
$9.84M 0.14%
75,355
-5,646
-7% -$717K
BND icon
122
Vanguard Total Bond Market
BND
$160B
$9.73M 0.13%
132,556
-2,018
-1% -$148K
TXRH icon
123
Texas Roadhouse
TXRH
$12.5B
$9.16M 0.13%
47,420
+980
+2% +$167K
IBDW icon
124
iShares iBonds Dec 2031 Term Corporate ETF
IBDW
$2.54B
$8.96M 0.12%
430,124
+36,897
+9% +$770K
XLK icon
125
State Street Technology Select Sector SPDR ETF
XLK
$122B
$8.74M 0.12%
45,890
+982
+2% +$168K

Similar funds

Glenview Trust's Q2 2026 Portfolio in Review

As of Q2 2026, Glenview Trust held 533 positions worth $7.23B, up 14% from $6.37B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Glenview Trust's Q2 2026 filing shows 33 new, 204 increased, 204 reduced and 16 closed positions. Its largest new stake was Avantis US Mid Cap Value ETF: 49,076 shares worth $3.95M. The largest sale was Procter & Gamble, an estimated $14.3M.

By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 30% a quarter earlier, followed by Technology and Financials.

  • Glenview Trust's largest Q2 2026 buy was Avantis US Mid Cap Value ETF: 49,076 shares worth $3.95M.
  • Glenview Trust added most to Emerson Electric in Q2 2026, an estimated $14.6M increase.
  • Glenview Trust's biggest Q2 2026 reduction was Procter & Gamble, cutting an estimated $14.3M.
  • Glenview Trust fully exited iShares Core Universal USD Bond ETF in Q2 2026, selling an estimated $601K.
  • Glenview Trust's ten largest holdings make up 35% of its $7.23B portfolio in Q2 2026.
  • Glenview Trust opened 33 new positions and closed 16 in Q2 2026.
  • Glenview Trust's portfolio value rose 14% quarter-over-quarter to $7.23B.

Based on Glenview Trust's 13F filing for Q2 2026, filed 11 Aug 2026.